Worldwide Market for Rheumatoid Arthritis and Lupus Treatments (Autoimmune Disease Markets)

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

• Introduction
• Scope and Methodology
• Size and Growth of the Market
• Leading Competitors

CHAPTER TWO: INTRODUCTION

• History of the Market
• Immune System
• Autoimmunity
• Genetic Factors
• Environmental Factors
• Gene Research
• Distribution
• Technology
• Demographics

CHAPTER THREE: MARKETS FOR RHEUMATOID ARTHRITIS

• Overview
• Description of Rheumatoid Arthritis
• Diagnosis
• Treatment Guidelines
• Economic Impact of Disease
• Trends in Insurance and Reimbursement
• Description of products
• Non-steroid Anti-inflammatory Drugs
• Biologic Treatments
• Disease Modifying Anti-rheumatic Drugs (DMARDs)
• Immunosuppressant and Other Biologic Drugs
• New Developments
• Market Overview
• Market by Product Type
• Market by Geographical Region
• Competitive Analysis
• Corporate Profiles
• Abbott Laboratories
• Amgen, Inc
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb
• Centocor, Inc.
• Genentech, Inc.
• Merck & Company, Inc.
• Novartis International AG
• Pfizer, Inc.
• Schering-Plough Corporation
• Wyeth

CHAPTER FOUR: MARKETS FOR LUPUS ERYTHEMATOSUS

• Overview
• Description of Lupus Erythematosus
• Diagnosis
• Risk Factors
• Treatment Guidelines
• Economic Impact of Disease
• Trends in Insurance and Reimbursement
• Description of products
• New Developments
• Market Overview
• Market by Product Type
• Market by Geographical Region
• Competitive Analysis
• Corporate Profiles
• Aspreva Pharmaceuticals Corporation
• Bristol-Myers Squibb
• Genelabs Technologies, Inc.
• Genentech, Inc.
• GlaxoSmithKline plc
• Human Genome Sciences
• La Jolla Pharmaceutical Company
• Roche
• UCB S.A.

CHAPTER FIVE: TOTAL MARKET SIZE AND FORECAST

• Overview
• Total Market Size and Forecast
• Markets by Segments
• Leading Competitors

CHAPTER SIX: LIST OF COMPANIES

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-1: The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, 2004-2011
• Figure 1-1: The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, 2004-2011

CHAPTER TWO: INTRODUCTION

• Table 2-1: World Population by Selected Geographical Region, 2006-2050
• Figure 2-1: World Population by Selected Geographical Region, 2006-2050
• Table 2-2: Estimated World Population by Age and Geographical Region, 2006
• Table 2-2: Estimated World Population by Age and Geographical Region, 2006

CHAPTER THREE: RHEUMATOID ARTHRITIS MARKETS

• Table 3-1: World Prevalence of Rheumatoid Arthritis by Region 25
• Figure 3-1: World Prevalence of Rheumatoid Arthritis, Percent by Region
• Table 3-2: Select Marketed Non-steroidal Anti-inflammatory Drugs
• Table 3-3: Selected Prescription Disease Modifying Anti-Rheumatic Drugs
• Table 3-4: Selected Prescription Immunosuppressant and Other Biologic Drugs
• Table 3-5: New Developments in Rheumatoid Arthritis
• Figure 3-2: Number of New Developments for Rheumatoid Arthritis by Development Phase
• Table 3-6: The World Market for Prescription Rheumatoid Arthritis Treatments, 2004-2011
• Figure 3-3: The World Market for Prescription Rheumatoid Arthritis Treatments, 2004-2011
• Table 3-7: The World Market for Prescription Rheumatoid Arthritis Treatments, by Product Type, 2004-2011
• Figure 3-4:The World Market for Prescription Rheumatoid Arthritis Treatments, by Product Type, 2004-2011
• Figure 3-5: The World Market for Prescription Rheumatoid Arthritis Treatments, by Product Type and Percent Distribution, 2004-2011
• Figure 3-6: The World Market for Prescription Rheumatoid Arthritis Treatments, by Percent and Product Type, 2006
• Figure 3-7: The World Market for Prescription Rheumatoid Arthritis Treatments, by Percent and Product Type, 2011
• Table 3-8: The World Market for Prescription Rheumatoid Arthritis, by Geographic Region, 2006
• Figure 3-8: The World Market for Prescription Rheumatoid Arthritis, by Geographic Region, 2006
• Table 3-9: Leading Suppliers' Shares of the World Market for Prescription Rheumatoid Arthritis Treatments, 2006
• Figure 3-9: Leading Suppliers' Shares of the World Market for Prescription Rheumatoid Arthritis Treatments, 2006

CHAPTER FOUR: LUPUS TREATMENT MARKETS

• Table 4-1: World Prevalence of Lupus by Region
• Figure 4-1: World Prevalence of Lupus, Percent by Region
• Table 4-2: Select Marketed Non-steroidal Anti-inflammatory Drugs
• Table 4-3: Selected Corticosteroids, Immunosuppressives and DMARDs
• Table 4-4: New Developments in Lupus Erythrematosus
• Figure 4-2: Number of New Developments for Lupus Erythrematosus by Development Phase Table 4-5: The World Market for Prescription Lupus Treatments, 2004-2011
• Figure 4-3: The World Market for Prescription Lupus Treatments, 2004-2011
• Table 4-6: The World Market for Prescription Lupus Treatments, by Product Type, 2004-2011
• Figure 4-4: The World Market for Prescription Lupus Treatments, by Product Type, 2004-2011
• Figure 4-5: The World Market for Prescription Lupus Treatments, by Product Type and Percent Distribution, 2004-2011
• Figure 4-6: The World Market for Prescription Lupus Treatments, by Percent and Product Type, 2006
• Figure 4-7: The World Market for Prescription Lupus Treatments, by Percent and Product Type, 2011
• Table 4-7: The World Market for Prescription Lupus Treatments, by Geographic Region, 2006
• Figure 4-8: The World Market for Prescription Lupus Treatments, by Geographic Region, 2006
• Table 4-8: Estimated Leading Suppliers' Shares of the World Market for Prescription Lupus Treatments, 2011
• Figure 4-9: Estimated Leading Suppliers' Shares of the World Market for Prescription Lupus Treatments, 2011

CHAPTER FIVE: WORLD MARKET SUMMARY

• Table 5-1: The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, 2004-2011
• Figure 5-1: The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, 2004-2011
• Table 5-2: The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, by Product Type, 2004-2011
• Figure 5-3: The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, by Product Type, 2004-2011
• Figure 5-4: The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, by Product Type and Percent Distribution, 2004-2011
• Figure 5-5: The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, by Percent and Product Type, 2006
• Figure 5-6: The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, by Percent and Product Type, 2011